Li F; Mei H; Gao Y, et al., Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer. Biomaterials 2017, 145, 56-71.
Li T Y; Du Y; Wang M C, et al., Cytotoxic Steroidal Saponins Containing a Rare Fructosyl from the Rhizomes of Paris polyphylla var. latifolia. Int J Mol Sci 2023, 24 (8).
Xin J; You T; Jiang X, et al., Caveolin-1 Alleviates Acetaminophen—Induced Hepatotoxicity in Alcoholic Fatty Liver Disease by Regulating the Ang II/EGFR/ERK Axis. International Journal of Molecular Sciences 2022, 23 (14), 7587.
Zhang F; Cui X; Yang K, et al., Activin A inhibits the migration of human lung adenocarcinoma A549 cells induced by EGF. Int Immunopharmacol 2024, 142 (Pt B), 113170.
Zhu F; Xu L; Li X, et al., Co-delivery of gefitinib and hematoporphyrin by aptamer-modified fluorinated dendrimer for hypoxia alleviation and enhanced synergistic chemo-photodynamic therapy of NSCLC. Eur J Pharm Sci 2021, 167, 106004.
Liang D; Su Z; Tian W, et al., Synthesis and screening of novel anthraquinone-quinazoline multitarget hybrids as promising anticancer candidates. Future Med Chem 2020, 12 (2), 111-126.
Wang P; Lan Q; Huang Q, et al., Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation. Biology 2024, 13 (8), 597.
Zhang C; Liu Y; Yang F, et al., MicroRNA-194-5p/Heparin-binding EGF-like growth factor signaling mediates dexamethasone-induced activation of pseudorabies virus in rat pheochromocytoma cells. Vet Microbiol 2024, 290, 109974.
Pan Z; Wang K; Chen Q, et al., SFI Enhances Therapeutic Efficiency of Gefitinib: An Insight into Reversal of Resistance to Targeted Therapy in Non-small Cell Lung Cancer Cells. J Cancer 2020, 11 (2), 334-344.
